Genitourinary System Carcinoma — Trials

Genitourinary System Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

4,916 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,498
Recruiting: 782
Ph III recruiting: 85
Growth YoY: +17.8%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (758)

clinicaltrialsPublishedShowing 251–268 of 268 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05128487	A Study of NDI 1150-101 in Patients With Solid Tumors	active not recruiting	Phase 1 / Phase 2	106	Nimbus Saturn, Inc.INDUSTRY	1	Nov 25, 2024	clinicaltrials
NCT02124421	HOT: HIPEC in Ovarian Cancer as Initial Treatment(CRS/HIPEC)	active not recruiting	Phase 2	32	Mercy Medical CenterOTHER	1	Nov 19, 2024	clinicaltrials